358 related articles for article (PubMed ID: 29481745)
21. Natural Product Splicing Inhibitors: A New Class of Antibody-Drug Conjugate (ADC) Payloads.
Puthenveetil S; Loganzo F; He H; Dirico K; Green M; Teske J; Musto S; Clark T; Rago B; Koehn F; Veneziale R; Falahaptisheh H; Han X; Barletta F; Lucas J; Subramanyam C; O'Donnell CJ; Tumey LN; Sapra P; Gerber HP; Ma D; Graziani EI
Bioconjug Chem; 2016 Aug; 27(8):1880-8. PubMed ID: 27412791
[TBL] [Abstract][Full Text] [Related]
22. The Recent Developments of ADCs with the Tubulysins as the Payloads.
Xiangrong X; Yao L; Yao A
Mini Rev Med Chem; 2023; 23(18):1797-1805. PubMed ID: 36825713
[TBL] [Abstract][Full Text] [Related]
23. Chimeric Small Antibody Fragments as Strategy to Deliver Therapeutic Payloads.
Aguiar S; Dias J; Manuel AM; Russo R; Gois PMP; da Silva FA; Goncalves J
Adv Protein Chem Struct Biol; 2018; 112():143-182. PubMed ID: 29680236
[TBL] [Abstract][Full Text] [Related]
24. Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry.
McCombs JR; Owen SC
AAPS J; 2015 Mar; 17(2):339-51. PubMed ID: 25604608
[TBL] [Abstract][Full Text] [Related]
25. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.
Boswell CA; Mundo EE; Zhang C; Bumbaca D; Valle NR; Kozak KR; Fourie A; Chuh J; Koppada N; Saad O; Gill H; Shen BQ; Rubinfeld B; Tibbitts J; Kaur S; Theil FP; Fielder PJ; Khawli LA; Lin K
Bioconjug Chem; 2011 Oct; 22(10):1994-2004. PubMed ID: 21913715
[TBL] [Abstract][Full Text] [Related]
26. UPLC-based assay to assess the hydrophobicity of Antibody-Drug Conjugate (ADC) payloads.
Pysz I; Jackson PJM; Barlow DJ; Rahman KM; Thurston DE
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jun; 1146():122075. PubMed ID: 32361467
[TBL] [Abstract][Full Text] [Related]
27. A simple LC/MRM-MS-based method to quantify free linker-payload in antibody-drug conjugate preparations.
Zmolek W; Bañas S; Barfield RM; Rabuka D; Drake PM
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():144-148. PubMed ID: 27311685
[TBL] [Abstract][Full Text] [Related]
28. Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers.
Salomon PL; Reid EE; Archer KE; Harris L; Maloney EK; Wilhelm AJ; Miller ML; Chari RVJ; Keating TA; Singh R
Mol Pharm; 2019 Dec; 16(12):4817-4825. PubMed ID: 31609629
[TBL] [Abstract][Full Text] [Related]
29. Site-Specific Quantitation of Drug Conjugations on Antibody-Drug Conjugates (ADCs) Using a Protease-Assisted Drug Deconjugation and Linker-like Labeling (PADDLL) Method.
Yang X; Seol H; Lin W; Xu X; Shen B; Qiu H; Li N
Anal Chem; 2021 Jul; 93(27):9549-9558. PubMed ID: 34196532
[TBL] [Abstract][Full Text] [Related]
30. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
[TBL] [Abstract][Full Text] [Related]
31. Antibody drug conjugates beyond cytotoxic payloads.
Hobson AD
Prog Med Chem; 2023; 62():1-59. PubMed ID: 37981349
[TBL] [Abstract][Full Text] [Related]
32. Quantitative Conjugated Payload Measurement Using Enzymatic Release of Antibody-Drug Conjugate with Cleavable Linker.
Rago B; Tumey LN; Wei C; Barletta F; Clark T; Hansel S; Han X
Bioconjug Chem; 2017 Feb; 28(2):620-626. PubMed ID: 28140559
[TBL] [Abstract][Full Text] [Related]
33. Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site.
Kumar A; Mao S; Dimasi N; Gao C
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961794
[TBL] [Abstract][Full Text] [Related]
34. The Analysis of Key Factors Related to ADCs Structural Design.
Tang H; Liu Y; Yu Z; Sun M; Lin L; Liu W; Han Q; Wei M; Jin Y
Front Pharmacol; 2019; 10():373. PubMed ID: 31068807
[TBL] [Abstract][Full Text] [Related]
35. Carfilzomib Is Not an Appropriate Payload of Antibody-Drug Conjugates Due to Rapid Inactivation by Lysosomal Enzymes.
Ma Y; Dela Cruz-Chuh J; Khojasteh SC; Dragovich PS; Pillow TH; Zhang D
Drug Metab Dispos; 2019 Aug; 47(8):884-889. PubMed ID: 31072822
[TBL] [Abstract][Full Text] [Related]
36. Total Synthesis in Search of Potent Antibody-Drug Conjugate Payloads. From the Fundamentals to the Translational.
Nicolaou KC; Rigol S
Acc Chem Res; 2019 Jan; 52(1):127-139. PubMed ID: 30575399
[TBL] [Abstract][Full Text] [Related]
37. Physical and Chemical Stability of Antibody Drug Conjugates: Current Status.
Ross PL; Wolfe JL
J Pharm Sci; 2016 Feb; 105(2):391-397. PubMed ID: 26869406
[TBL] [Abstract][Full Text] [Related]
38. Tuning the Diels-Alder Reaction for Bioconjugation to Maleimide Drug-Linkers.
St Amant AH; Lemen D; Florinas S; Mao S; Fazenbaker C; Zhong H; Wu H; Gao C; Christie RJ; Read de Alaniz J
Bioconjug Chem; 2018 Jul; 29(7):2406-2414. PubMed ID: 29932647
[TBL] [Abstract][Full Text] [Related]
39. High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers.
Ohri R; Bhakta S; Fourie-O'Donohue A; Dela Cruz-Chuh J; Tsai SP; Cook R; Wei B; Ng C; Wong AW; Bos AB; Farahi F; Bhakta J; Pillow TH; Raab H; Vandlen R; Polakis P; Liu Y; Erickson H; Junutula JR; Kozak KR
Bioconjug Chem; 2018 Feb; 29(2):473-485. PubMed ID: 29425028
[TBL] [Abstract][Full Text] [Related]
40. In vivo testing of drug-linker stability.
Abecassis PY; Amara C
Methods Mol Biol; 2013; 1045():101-16. PubMed ID: 23913143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
